Doctor profile · Federal record
Dr. Matthew Carraro, M.D.
Neurology Physician (CMS: Neurology) · Student in an Organized Health Care Education/Training Program · Charlotte, NC
- NPI 1437441052
- Accepts Medicare
- 15 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6060 Piedmont Row Dr S Ste 400
Charlotte, NC 282873884
(704) 664-8060
fax (704) 662-3458 - Mailing address
-
Po Box 1845
Statesville, NC 286871845
Credentials & registration
- NPI registered
- May 2011 — 15 yrs on file
- Profile last updated
- August 7, 2023
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- North Carolina #2016-01480
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437441052. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,706
Distinct HCPCS
10
Medicare allowed
$585,999
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2350 |
Injection, ocrelizumab, 1 mg | 10,200 | 11 | $52 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 124 | 85 | $118 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 111 | 67 | $154 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 79 | 54 | $85 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 56 | 14 | $24 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 47 | 47 | $158 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 29 | 15 | $108 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 25 | 13 | $5 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 24 | 13 | $1 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 11 | 11 | $188 |
In context: peer comparison
Among 36 peers in this city , average services per provider: 360. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$142,911
Transactions
140
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| TG Therapeutics, Inc. | 48 | $70,995.17 | |
| EMD Serono, Inc. | 30 | $36,752.59 | |
| GENZYME CORPORATION | 11 | $17,801.98 | |
| Biogen, Inc. | 16 | $11,938.81 | |
| Novartis Pharmaceuticals Corporation | 9 | $4,876.38 | |
| PFIZER INC. | 10 | $183.12 | |
| Celgene Corporation | 5 | $105.67 | |
| ABBVIE INC. | 3 | $85.21 | |
| Genentech USA, Inc. | 2 | $50.18 | |
| ANI Pharmaceuticals, Inc. | 1 | $24.94 | |
| Amgen Inc. | 1 | $22.91 | |
| Lundbeck LLC | 1 | $20.24 | |
| Teva Pharmaceuticals USA, Inc. | 1 | $18.97 | |
| Neurocrine Biosciences, Inc. | 1 | $18.31 | |
| Alexion Pharmaceuticals, Inc. | 1 | $16.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
494
Patients
107
Total drug cost
$757,120
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Baclofen | Generic | 71 | 31 | $3,230 |
| Kesimpta Pen (Ofatumumab) | Brand | 65 | 0 | $680,217 |
| Gabapentin | Generic | 57 | 22 | $3,242 |
| Dalfampridine Er (Dalfampridine) | Brand | 56 | 14 | $32,999 |
| Amitriptyline Hcl | Generic | 36 | 0 | $669 |
| Pregabalin | Generic | 34 | 13 | $2,339 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | Brand | 33 | 11 | $1,058 |
| Nurtec Odt (Rimegepant Sulfate) | Brand | 22 | 0 | $28,963 |
| Methylprednisolone | Generic | 21 | 16 | $214 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 17 | 0 | $1,814 |
Frequently asked questions
What is Dr. Matthew Carraro's medical specialty?
Dr. Matthew Carraro practices Neurology Physician in Charlotte, NC.
Where does Dr. Matthew Carraro practice?
Dr. Matthew Carraro practices at 6060 Piedmont Row Dr S Ste 400, Charlotte, NC 282873884. Office phone: 7046648060.
What is Dr. Matthew Carraro's NPI?
Dr. Matthew Carraro's National Provider Identifier (NPI) is 1437441052, issued by NPPES.
Does Dr. Matthew Carraro accept Medicare assignment?
Yes. Dr. Matthew Carraro accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Carraro commonly perform?
Top Medicare-reported procedures in 2023: Injection, ocrelizumab, 1 mg (HCPCS J2350); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.